1 / 251
文档名称:

Springer - Verlag - Advances In Biochemical Engineering - Biotechnology - Modern Adva.pdf

格式:pdf   页数:251
下载后只包含 1 个 PDF 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

Springer - Verlag - Advances In Biochemical Engineering - Biotechnology - Modern Adva.pdf

上传人:bolee65 2014/7/19 文件大小:0 KB

下载得到文件列表

Springer - Verlag - Advances In Biochemical Engineering - Biotechnology - Modern Adva.pdf

文档介绍

文档介绍:Preface
Preface
Due to their versatility and resolution, chromatographic separations plex
mixtures of biologicals are used for many purposes in academia and industry. If
anything, recent developments in the life sciences have increased the interest
and need for chromatography be it for quality control, proteomics or the down-
stream processing of the high value products of modern biotechnology. How-
ever, the many “challenges”of present day chromatography and especially of the
HPLC of biomacromolecules such as proteins, are also present in the mind of
any practitioner. In fact, some of these latter were such hindrances that much
research was necessary in order to e and circumvent them. This book
introduces the reader to some of the recently proposed solutions. Capillary elec-
trochromatography (CEC),for example,the latest and most promising branch of
analytical chromatography,is still hindered from finding broader application by
difficulties related to something as simple as the packing of a suitable column.
The latest solutions for this but also the state of art of CEC in general are dis-
cussed in the chapter written by Frantisek Svec. The difficulty bining
speed, resolution and capacity when using the classical porous bead type sta-
tionary phases has even been called the “dilemma of protein chromatography”.
Much progress has been made in this area by the advent of monolithic and relat-
ed continuous stationary phases. plex nature of many of the samples to
be analyzed and separated in biochromatography often requires the use of some
highly specific (“affinity”) ligands. Since they can be raised in a specific manner
to many bioproducts,protein ligands such as antibodies have allowed some very
selective solutions in the past. However, they also are known to have some dis-
advantages, including the immunogenicity (toxicity) of ligands contaminating
the final products, or the low stability of such ligands, which prevents repeated
usage of t